LINDA CRUMP: Open Payments
NPI 1144229998 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 24 payments from 14 companies in 2025. Trend: 2023 $485 · 2024 $145 · 2025 $567
Food & beverage: $499Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $190 |
| Janssen Biotech, Inc. | 4 | $90 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Celgene Corporation | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $23 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $19 |
Products named: ERLEADA, IMFINZI, CALQUENCE, KEYTRUDA, REBLOZYL, SCEMBLIX, Xtandi, Trodelvy.
Industry payments across KY — which companies pay providers there.
